Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02096692 · ClinicalTrials.gov registry record
ProMRI Study of the Iforia ICD System (Phase C)
A clinical trial, sponsored by Biotronik.
- Completed
- Registry status
- 154
- Enrollment target
NCT02096692: Completed study, sponsored by Biotronik.
NCT02096692 is a clinical trial that has completed, run by Biotronik. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02096692 has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
The objective of the ProMRI Study is to demonstrate the clinical safety of the ProMRI ICD System when used under specific MRI conditions.
Interventions
- OTHER Magnetic Resonance Imaging (MRI) scan
- DEVICE Patients with a ProMRI ICD System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-06 |
What the finished NCT02096692 record still lists
NCT02096692 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) scan is the first listed.
NCT02096692 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02096692 about?
NCT02096692 is a clinical study titled "ProMRI Study of the Iforia ICD System (Phase C)". The objective of the ProMRI Study is to demonstrate the clinical safety of the ProMRI ICD System when used under specific MRI conditions.
What is the current status of trial NCT02096692?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2014-06. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02096692?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) scan (OTHER), Patients with a ProMRI ICD System (DEVICE).
Who is sponsoring clinical trial NCT02096692?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia